Background Australia has demonstrated high efficacy and safety of medical termination of
pregnancy (MToP) using a mifepristone–buccal misoprostol regime. The provision of …

Abstract Background Australian Government approval in 2012 for the use of mifepristone
and misoprostol for medical termination of pregnancy (MTOP) allows general practitioners …

Objective To understand better rural women's experiences in obtaining a medical
termination of pregnancy (MToP) through a rural primary healthcare service in Victoria …

Purpose The purpose of this paper is to understand women's experiences, acceptability and
outcomes of using the medical termination of pregnancy (MTP). The study is conducted at …

In 2018, termination of pregnancy (TOP) was legalised in Ireland. 1 Healthcare
professionals expressed concern regarding the short interval between the passing of the …

Background The World Health Organization has indicated that GPs can safely and
effectively provide mifepristone and misoprostol for medical termination of pregnancy (TOP) …

Background Mifepristone, followed 48 hours later by administration of misoprostol, is a well-
established regimen for medical termination of pregnancy (TOP). Although this regimen is …

Objective To explore the experiences of women in Scotland who return home to complete
medical termination of pregnancy (TOP)≤ 63 days of gestation, after being administered …

Objective: Evaluate satisfaction and experience with telemedicine and home use of
mifepristone and misoprostol for abortion to 10 weeks' gestation. Design: Cross-sectional …

Background Access to medical termination of pregnancy (MToP) services in regional
Queensland remains inadequate and it is still possible for women and providers to be …